AAO

Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.

American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's virtual annual meeting — kicking off Nov. 13-15.

American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15.

Anne L. Coleman, MD, PhD, shares advice for others who are interested in pursuing a leadership role based on 5 dimensions of centered leadership.

The American Academy of Ophthalmology (AAO) is taking its annual meeting virtual amid the COVID-19 pandemic.

Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

Chuck Hess provides a company update at the OIS@AAO meeting in Chicago, Oct. 2018.

Erin D. Stahl, MD, discusses why it's important to diagnose and treat children with keratoconus at the earliest signs of development for successful outcomes during the AAO 2018 meeting in Chicago.

Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.

Joint event to feature plenty of symposia, practice management programs, product innovations

Clinical trial data focusing on treatment for age-related macular degeneration (AMD) have been a highlight at many recent ophthalmology meetings. Here are a few of the latest clinical trials that physicians need to be aware.

Since February is designated Age-Related Macular Degeneration Awareness month. For healthcare providers, there are numerous resources available to help promote awareness to patients and to encourage patients to continue (or start) annual visual exams.